You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Rifampicin Market Research Report 2021 Professional Edition

Rifampicin, also known as rifampin, is an antibiotic used to treat several types of bacterial infections, including tuberculosis, mycobacterium avium complex, leprosy, and Legionnaire's disease. Common side effects include nausea, vomiting, diarrhea, and loss of appetite.
Market Analysis and Insights: Global Rifampicin Market
The global Rifampicin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Rifampicin Scope and Segment
The global Rifampicin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rifampicin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Oral
Intravenous Injection
By the end users/application, this report covers the following segments
Tuberculosis
Leprosy
Legionnaire's Disease
Others
Competitive Landscape:
The report provides a list of all the key players in the Rifampicin market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Rifampicin key manufacturers in this market include:
Sanofi
Wellona Pharma
AVANSCURE LIFESCIENCES
Hebei Xingang Pharmaceutical
Mercator Pharmaceutical Solutions
ASIAN PHARMACY
1 Rifampicin Market Overview
1.1 Rifampicin Product Overview
1.2 Rifampicin Market Segment by Type
1.2.1 Oral
1.2.2 Intravenous Injection
1.3 Global Rifampicin Market Size by Type
1.3.1 Global Rifampicin Market Size Overview by Type (2016-2027)
1.3.2 Global Rifampicin Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Rifampicin Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Rifampicin Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Rifampicin Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Rifampicin Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Rifampicin Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Rifampicin Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Rifampicin Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Rifampicin Sales Breakdown by Type (2016-2021)
1.4.2 Europe Rifampicin Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Rifampicin Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Rifampicin Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Rifampicin Sales Breakdown by Type (2016-2021)

2 Global Rifampicin Market Competition by Company
2.1 Global Top Players by Rifampicin Sales (2016-2021)
2.2 Global Top Players by Rifampicin Revenue (2016-2021)
2.3 Global Top Players Rifampicin Price (2016-2021)
2.4 Global Top Manufacturers Rifampicin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Rifampicin Market Competitive Situation and Trends
2.5.1 Rifampicin Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Rifampicin Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rifampicin as of 2020)
2.7 Date of Key Manufacturers Enter into Rifampicin Market
2.8 Key Manufacturers Rifampicin Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Rifampicin Status and Outlook by Region
3.1 Global Rifampicin Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Rifampicin Historic Market Size by Region
3.2.1 Global Rifampicin Sales in Volume by Region (2016-2021)
3.2.2 Global Rifampicin Sales in Value by Region (2016-2021)
3.2.3 Global Rifampicin Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Rifampicin Forecasted Market Size by Region
3.3.1 Global Rifampicin Sales in Volume by Region (2022-2027)
3.3.2 Global Rifampicin Sales in Value by Region (2022-2027)
3.3.3 Global Rifampicin Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Rifampicin by Application
4.1 Rifampicin Market Segment by Application
4.1.1 Tuberculosis
4.1.2 Leprosy
4.1.3 Legionnaire's Disease
4.1.4 Others
4.2 Global Rifampicin Market Size by Application
4.2.1 Global Rifampicin Market Size Overview by Application (2016-2027)
4.2.2 Global Rifampicin Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Rifampicin Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Rifampicin Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Rifampicin Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Rifampicin Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Rifampicin Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Rifampicin Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Rifampicin Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Rifampicin Sales Breakdown by Application (2016-2021)
4.3.2 Europe Rifampicin Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Rifampicin Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Rifampicin Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Rifampicin Sales Breakdown by Application (2016-2021)

5 North America Rifampicin by Country
5.1 North America Rifampicin Historic Market Size by Country
5.1.1 North America Rifampicin Sales in Volume by Country (2016-2021)
5.1.2 North America Rifampicin Sales in Value by Country (2016-2021)
5.2 North America Rifampicin Forecasted Market Size by Country
5.2.1 North America Rifampicin Sales in Volume by Country (2022-2027)
5.2.2 North America Rifampicin Sales in Value by Country (2022-2027)

6 Europe Rifampicin by Country
6.1 Europe Rifampicin Historic Market Size by Country
6.1.1 Europe Rifampicin Sales in Volume by Country (2016-2021)
6.1.2 Europe Rifampicin Sales in Value by Country (2016-2021)
6.2 Europe Rifampicin Forecasted Market Size by Country
6.2.1 Europe Rifampicin Sales in Volume by Country (2022-2027)
6.2.2 Europe Rifampicin Sales in Value by Country (2022-2027)

7 Asia-Pacific Rifampicin by Region
7.1 Asia-Pacific Rifampicin Historic Market Size by Region
7.1.1 Asia-Pacific Rifampicin Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Rifampicin Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Rifampicin Forecasted Market Size by Region
7.2.1 Asia-Pacific Rifampicin Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Rifampicin Sales in Value by Region (2022-2027)

8 Latin America Rifampicin by Country
8.1 Latin America Rifampicin Historic Market Size by Country
8.1.1 Latin America Rifampicin Sales in Volume by Country (2016-2021)
8.1.2 Latin America Rifampicin Sales in Value by Country (2016-2021)
8.2 Latin America Rifampicin Forecasted Market Size by Country
8.2.1 Latin America Rifampicin Sales in Volume by Country (2022-2027)
8.2.2 Latin America Rifampicin Sales in Value by Country (2022-2027)

9 Middle East and Africa Rifampicin by Country
9.1 Middle East and Africa Rifampicin Historic Market Size by Country
9.1.1 Middle East and Africa Rifampicin Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Rifampicin Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Rifampicin Forecasted Market Size by Country
9.2.1 Middle East and Africa Rifampicin Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Rifampicin Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Rifampicin Business
10.1 Sanofi
10.1.1 Sanofi Corporation Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Rifampicin Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Sanofi Rifampicin Products Offered
10.1.5 Sanofi Recent Development
10.2 Wellona Pharma
10.2.1 Wellona Pharma Corporation Information
10.2.2 Wellona Pharma Introduction and Business Overview
10.2.3 Wellona Pharma Rifampicin Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Sanofi Rifampicin Products Offered
10.2.5 Wellona Pharma Recent Development
10.3 AVANSCURE LIFESCIENCES
10.3.1 AVANSCURE LIFESCIENCES Corporation Information
10.3.2 AVANSCURE LIFESCIENCES Introduction and Business Overview
10.3.3 AVANSCURE LIFESCIENCES Rifampicin Sales, Revenue and Gross Margin (2016-2021)
10.3.4 AVANSCURE LIFESCIENCES Rifampicin Products Offered
10.3.5 AVANSCURE LIFESCIENCES Recent Development
10.4 Hebei Xingang Pharmaceutical
10.4.1 Hebei Xingang Pharmaceutical Corporation Information
10.4.2 Hebei Xingang Pharmaceutical Introduction and Business Overview
10.4.3 Hebei Xingang Pharmaceutical Rifampicin Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Hebei Xingang Pharmaceutical Rifampicin Products Offered
10.4.5 Hebei Xingang Pharmaceutical Recent Development
10.5 Mercator Pharmaceutical Solutions
10.5.1 Mercator Pharmaceutical Solutions Corporation Information
10.5.2 Mercator Pharmaceutical Solutions Introduction and Business Overview
10.5.3 Mercator Pharmaceutical Solutions Rifampicin Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Mercator Pharmaceutical Solutions Rifampicin Products Offered
10.5.5 Mercator Pharmaceutical Solutions Recent Development
10.6 ASIAN PHARMACY
10.6.1 ASIAN PHARMACY Corporation Information
10.6.2 ASIAN PHARMACY Introduction and Business Overview
10.6.3 ASIAN PHARMACY Rifampicin Sales, Revenue and Gross Margin (2016-2021)
10.6.4 ASIAN PHARMACY Rifampicin Products Offered
10.6.5 ASIAN PHARMACY Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Rifampicin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Rifampicin Industrial Chain Analysis
11.4 Rifampicin Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Rifampicin Distributors
12.3 Rifampicin Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140